What this means
This is a trial that is still signing up people, so no results are in yet. It asks whether a device that adds sensory signals from the legs eases walking.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 65–95
- Where
- 1 site, including Florida
The science
- Registered title
- Walking Sensation Study
- Trial ID
- NCT06975423 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Aging, Sensory Deficit
- What is tested
- Active lower-limb neuroprosthesis, Inactive lower-limb neuroprosthesis
- Sponsor
- University of Florida
- Ages
- 65 Years to 95 Years
- Dates
- First posted May 16, 2025 · updated Oct 6, 2026
Registry summary
The primary objective of this new line of research is to test whether augmenting sensory information from the legs, using Walkasins sensory neuroprosthesis, can enhance performance of a complex walking task in older adults with foot sensory impairment. The overarching hypothesis is that Walkasins will enhance the automaticity and reduce cognitive demand of walking in older adults with foot sensory impairments, as measured by reduced prefrontal activity, decreased dual-task costs, and lower gait variability.
Sites (1)
- Clinical and Translational Research Building, Gainesville, Florida, United States